Liver Transplantation:  Information on allocation of livers, recurrent HCV after transplantation, treatment of HCV before and after liver transplantation, post transplantation disease progression, and long term outcomes after liver transplantation

 

·        Allocation/General

o       601. Assessment of liver transplant candidates by an addiction medicine specialist : a prospective study

o       611. Development of a UK Score for Patients with End-stage Liver Disease

o       612. Proposal of New Selection Criteria for Living Donor Liver Transplantation Candidates for Hepatocellular Carcinoma

o       625. Should donor organs and recipients be matched in liver transplantation? An analysis of the United Kingdom and Ireland Liver Transplant Database

 

·        Allocation/MELD

o       552. MELD-Na is superior to other organ allocation systems   (updated November 5, 2007)

o       564. Implementation of a liver allocation system based on MELD score in three transplant centers of the same city. Can the score differences be solved? (updated November 5, 2007)

o       598. Hepatocellular Carcinoma (HCC) in Patients with HCV versus non-HCV Cirrhosis: Graft and Patient Survival after Liver Transplantation (LT) in Pre-MELD and MELD Era

o       603. Long Term Outcomes Of Liver Transplantation In A High-MELD Cohort

o       618. High MELD scores do not predict one-year survival rate of patients with a small-for-size graft in adult living donor liver trasplantation

o       624. Does Health Related Quality of Life Correlate with the Model for End Stage Liver Disease Score Before Liver Transplantation?

 

·        General

o       521. Chronic hepatitis E : a new entity in organ transplant patients (updated November 4, 2007)

o       527. Comparison between hepatic elasticity measurements (Fibroscan®) and liver biopsy in patients transplanted for HCV cirrhosis (updated November 4, 2007)

o       533. High Prevalence of Glomerulonephritis in Patients with End-stage HCV-induced Cirrhosis (updated November 4, 2007)

o       543. What is the risk of HBV transmission in recipients of liver graft from HBc Positive Antibody, HBs Negative Antigen donors? A single center experience over 10 years

o       561. Combined liver heart transplantation in the United States (updated November 5, 2007)

o       576. Sexual dysfunction before and after liver transplantation (LT)

o       589. Pre-transplant variables predict qualify of life in liver transplant recipients

o       602. The Readability of Health Education Materials for Liver Transplant Patients (updated November 5, 2007)

o       621. Use of Donation-after-Cardiac-Death (DCD) Donors for Combined Liver and Kidney Transplantation

 

·        Liver Cancer

o       585. Trends in Liver Transplantation for Hepatocellular Carcinoma in the United States

o       598. Hepatocellular Carcinoma (HCC) in Patients with HCV versus non-HCV Cirrhosis: Graft and Patient Survival after Liver Transplantation (LT) in Pre-MELD and MELD Era

o       612. Proposal of New Selection Criteria for Living Donor Liver Transplantation Candidates for Hepatocellular Carcinoma

o       626. Liver Transplantation for Hepatocellular Carcinoma : Validation of a new Prognostic Score Predicting Overall Survival

 

·        Living Liver Donors

o       554. Graft Survival after Living Donor or Cadaveric Liver transplantation: An Analysis Stratified by Donor Risk (updated November 5, 2007)

o       612. Proposal of New Selection Criteria for Living Donor Liver Transplantation Candidates for Hepatocellular Carcinoma

o       616. Transplant costs of adult living donor liver transplantation at an experienced transplant center are similar to deceased donor liver transplantation despite increased surgical costs

o       617. Successful Algorithm for Selective Liver Biopsy in the Right Lobe Liver Donor (RLD)

o       618. High MELD scores do not predict one-year survival rate of patients with a small-for-size graft in adult living donor liver trasplantation (updated November 5, 2007)

 

·        Post Transplant

o       29. Impact of HIV on Survival after Liver Transplantation. Analysis of United Network for Organ Sharing (UNOS) Database

o       522. Post-Liver Transplant Survival in Hepatitis C Patients is Improving, Not Declining (updated November 4, 2007)

o       520. Evaluation of Week 12 Response on SVR in HCV Post Transplant Patients Undergoing PEG/RBV Therapy (updated November 4, 2007)

o       531. Multicenter randomized trial in HCV-infected patients treated with peginterferon alfa-2a and ribavirin followed by ribavirin alone after liver transplantation: Final report (updated November 4, 2007)

o       532. Hepatitis C Virus (HCV) Infection is a Protective Factor for Hepatitis B Virus Reactivation (HBVr) After Receiving Hepatitis B Core Positive (HBcAb+) Donors for Liver Transplantation (LT) (updated November 4, 2007)

o       539. Patients with HCV-Induced Cirrhosis with Immune-complex Glomerulonephritis Have Progressive Proteinuria After Liver Transplantation

o       545. Predicting Cardiovascular Events After Liver Transplantation (updated November 4, 2007)

o       546. Transplantation Trends in Recipients Over the age of 65 (updated November 4, 2007)

o       558. Smoking related morbidity and mortality post liver transplantation (updated November 12, 2007)

o       566. Outcomes of Transplantation with previously Refused Donor Livers in Region 8 (updated November 5, 2007)

o       593. GB Virus-C Infection is Associated with Better 10-Year-Survival of Liver Transplant Recipients (updated November 5, 2007)

o       598. Hepatocellular Carcinoma (HCC) in Patients with HCV versus non-HCV Cirrhosis: Graft and Patient Survival after Liver Transplantation (LT) in Pre-MELD and MELD Era (updated November 5, 2007)

o       603. Long Term Outcomes Of Liver Transplantation In A High-MELD Cohort

 

o       Recurrence

§        526. Sustained virological response in patients successfully treated for recurrent hepatitis C following liver transplantation is highly durable.

§        530. Metabolic Syndrome is an Independent Predictor of Fibrosis Progression in Patients with Recurrent Hepatitis C (HCV) After Liver Transplantation (LT) Using Serial Biopsy Specimens

§        536. Serum Levels Of Fibrosis Progression Biomarkers Measured Early After LT Are Associated To Severe HCV Recurrence  (updated November 4, 2007)

§        538. Transient elastography (TE) is an accurate tool in monitoring liver transplanted (LT) patients with recurrent hepatitis C

§        540. Fibrosis Progression on Protocol Liver Biopsies In Patients With Recurrent HCV Following Liver Transplantation (updated November 4, 2007)

§        541. Consensus Interferon Therapy for Hepatitis C Recurrence After Pegylated Interferon Failure Post Liver Transplant

§        544. Response of fibrosing cholestatic recurrent hepatitis C following liver transplantation to combination interferon/ribavirin therapy (updated November 5, 2007)

§        547. The effect of disease recurrence on graft survival following orthotopic liver transplantation (updated November 4, 2007)

§        553. Long term results of a randomized trial of tacrolimus monotherapy versus triple therapy in HCV cirrhosis liver transplant recipients. (updated November 5, 2007)